Clinical trial

Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001

NCT03004495

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-01-01

PhasePHASE1

Study timeline

Study start (unknown)2016-01-01Date precision: month

Registry last updated2016-12-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Copdunresolved

Interventions

CHF5259 and CHF6001DRUG

CHF5259 + placeboDRUG

CHF6001 + placeboDRUG

PlaceboOTHER

Sponsors & collaborators

Chiesi Farmaceutici S.p.A.lead sponsor

Quintiles, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03004495 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.